What is the appropriate adult dosing, contraindications, and precautions for promethazine/dextromethorphan (Promethazine DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Promethazine DM: Dosing, Contraindications, and Precautions

Promethazine DM (promethazine with dextromethorphan) is an oral combination product used for cough and upper respiratory symptoms, with standard adult dosing of promethazine 6.25-25 mg combined with dextromethorphan 15-30 mg every 4-6 hours, but injectable promethazine should be avoided entirely due to severe tissue injury risks including gangrene and amputation.

Adult Dosing

Oral Promethazine Component

  • Standard dose: 12.5-25 mg every 4-6 hours as needed 1
  • Maximum total daily dose: 100 mg 2
  • For cough/cold symptoms: Start with 12.5 mg and titrate to the smallest effective dose 1
  • Lower doses (6.25 mg) are equally effective for nausea with less sedation compared to 12.5 mg 3

Dextromethorphan Component

  • Therapeutic dose: 30 mg orally, though maximum cough suppression occurs at 60 mg 4
  • Dosing interval: Every 4-6 hours as needed
  • Note: Most over-the-counter preparations contain subtherapeutic doses 4

Critical Safety Warnings

Injectable Promethazine - AVOID

The most important clinical recommendation is to never use injectable promethazine due to catastrophic tissue injury risks. 5, 6

  • Severe complications include: Tissue necrosis, gangrene, and limb amputation with inadvertent perivascular extravasation, intra-arterial injection, or intraneural infiltration 7
  • FDA updated labeling in December 2023 to emphasize intramuscular preference and strict dilution/administration protocols 5
  • Professional organizations recommend complete removal from hospital formularies 6

Contraindications

  • Children under 2 years of age - BLACK BOX WARNING due to fatal respiratory depression risk 1
  • Avoid in pediatric patients for unknown etiology vomiting 1
  • Concurrent MAOI use with dextromethorphan can cause serotonin syndrome 8
  • Concurrent SSRI use with dextromethorphan increases serotonin syndrome risk - requires 8-hour monitoring 8

Adverse Effects Profile

Promethazine

  • Common: Hypotension (especially with IV use), sedation, dry mouth, blurred vision 7, 2
  • Serious:
    • Respiratory depression 7
    • Neuroleptic malignant syndrome 2
    • Extrapyramidal effects (restlessness to oculogyric crises) 7, 2
    • Psychiatric effects in children: Anxiety, depression, suicidal ideation, intentional self-injury 9

Dextromethorphan

  • Generally well-tolerated with infrequent, non-severe reactions 10
  • Dose-related effects: Neurological, cardiovascular, and gastrointestinal disturbances 10
  • Abuse potential is the most significant safety concern 10
  • Overdose threshold: >7.5 mg/kg requires emergency evaluation 8

Pharmacokinetics

Promethazine

  • Onset: Within 5 minutes (IV), several minutes (oral) 2
  • Duration: 4-6 hours 7, 2
  • Half-life: 9-16 hours 2
  • Administration rate (if IV unavoidable): ≤25 mg/min to minimize hypotension 7

Dextromethorphan

  • Onset: Several minutes 4
  • Duration: 4-6 hours 4
  • Peak effect: 15 minutes 4

Clinical Efficacy Considerations

Dextromethorphan Evidence

The evidence for dextromethorphan in acute viral cough is mixed and inconsistent 11, 4:

  • Some studies show 40-60% reduction in cough counts at higher doses (30-60 mg) 11
  • Other studies show no significant difference from placebo 11
  • May be more effective in children than adults for acute URI 11
  • Simple remedies like honey and lemon may be equally effective for acute viral cough 4

Promethazine Evidence

  • Primarily studied as adjunct for procedural sedation, not as primary cough suppressant 7, 2
  • Reduces requirements for other sedatives (narcotics, benzodiazepines) by 10-20% 7, 2

Safer Alternatives

Given the risks of promethazine, consider these alternatives 12, 6:

For Nausea/Vomiting

  • 5-HT3 antagonists (ondansetron, granisetron): Superior safety profile
  • Dopamine antagonists (metoclopramide): Comparable efficacy
  • Multimodal approach: Target multiple receptor pathways simultaneously

For Cough Suppression

  • Dextromethorphan alone: Effective without promethazine risks
  • Menthol inhalation: Acute, short-lived cough suppression 4
  • First-generation antihistamines: For nocturnal cough (diphenhydramine 25-50 mg) 4
  • Avoid codeine/pholcodine: No greater efficacy than dextromethorphan with worse side effects 4

Monitoring and Follow-up

For Dextromethorphan Overdose

  • 5-7.5 mg/kg ingestion: Follow-up every 2 hours for 4 hours 8
  • >7.5 mg/kg ingestion: Emergency department referral 8
  • Asymptomatic >4 hours post-ingestion: Can observe at home 8

For Promethazine Toxicity

  • Main feature is delirium (dose-dependent) 13:
    • 250 mg: 31% probability
    • 500 mg: 42% probability
    • 1000 mg: 55% probability
  • Activated charcoal within 2 hours reduces delirium probability 13

Key Clinical Pitfalls

  1. Never use injectable promethazine - tissue injury risk outweighs any benefit 5, 6
  2. Avoid in children <2 years - fatal respiratory depression 1
  3. Check for MAOI/SSRI use before prescribing dextromethorphan 8
  4. Most OTC dextromethorphan doses are subtherapeutic - may need 60 mg for effect 4
  5. Promethazine causes significant sedation - warn about driving/operating machinery
  6. Psychiatric effects in children - monitor for mood changes, suicidal ideation 9

References

Guideline

aga institute review of endoscopic sedation.

Gastroenterology, 2007

Research

A comparison of two differing doses of promethazine for the treatment of postoperative nausea and vomiting.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2015

Research

Promethazine: A Review of Therapeutic Uses and Toxicity.

The Journal of emergency medicine, 2024

Research

Injectable promethazine in clinics and hospitals: What's the alternative?

JAAPA : official journal of the American Academy of Physician Assistants, 2025

Research

Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal.

QJM : monthly journal of the Association of Physicians, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.